FDA Approves Over-the-Counter Naloxone
On March 29th, the the U.S. Food and Drug Administration (FDA) approved the first nonprescription, “over-the-counter” (OTC) naloxone nasal spray, Narcan. This…
March 30, 2023 by NYSAM
On March 29th, the the U.S. Food and Drug Administration (FDA) approved the first nonprescription, “over-the-counter” (OTC) naloxone nasal spray, Narcan. This…
January 30, 2023 by NYSAM
Join the Hazelden Betty Ford Graduate School for our virtual open house on Thursday, February 9. We will come together…
January 26, 2023 by NYSAM
Addiction Policy and the Consolidated Appropriations Act Live Webinar Date: January 31 from 3:00 – 4:00 pm EST This 1-hour…
December 13, 2022 by NYSAM
Respectful & Equitable Access to Comprehensive Healthcare (REACH) Program Mount Sinai Hospital Internal Medicine Associates The Buprenorphine Nurse (BN) is…
November 29, 2022 by NYSAM
In order to increase the visibility of the excellent work being done by medical students, residents, and addiction medicine/addiction psychiatry…
November 23, 2022 by NYSAM
Dear NYSAM constituents – please find information below about ASAM’s Diversity Travel Scholarship, now available for the annual meeting. ASAM’s…